iwNHL is an annual workshop led by scientific leaders in NHL, which will bring together top clinical and translational research minds to discuss the latest advances.

In collaboration with relevant stakeholders, the aim is to identify key clinical and translational research priorities to help improve clinical care of non-Hodgkin lymphoma.

In keeping with the ethos of iwNHL, the emphasis of the workshop will be on short, high-level presentations, complemented by sessions of interactive debate and panel discussions.

Workshop Location

iwNHL 2026 Scientific Committee

John Gribben (Chair), Barts Cancer Institute, London, UK

Jason Westin (Co-Chair), University of Texas MD Anderson Cancer Center, Houston, Texas

Stephen Ansell, Mayo Clinic, Rochester, Minnesota

Catherine Bollard, Children’s National Research Institute, Washington, DC

Martin Hutchings, Rigshospitalet, Copenhagen, Denmark

Laurence de Leval, University Hospital of Lausanne, Switzerland

David Maloney, Fred Hutchinson Cancer Center, Seattle, WA

Loretta Nastoupil, University of Texas MD Anderson Cancer Center, Houston, TX

Laurie Sehn, BC Cancer Centre for Lymphoid Cancer, Vancouver, Canada

Marion Subklewe, Gene Center, Ludwig-Maximilians-Universität München, Munich, Germany